Artemisinin Imp-A is a synthetic byproduct derived from the partial oxidation of the 1,2,4-trioxane core in artemisinin, resulting in a hydroxylated derivative at the C-10 position. This compound retains the sesquiterpene lactone scaffold but exhibits altered oxygenation patterns, including a cleaved peroxide bridge and an additional hydroxyl group. Its structural similarity to artemisinin enables its use as an HPLC reference standard for monitoring synthetic pathway purity in antimalarial drug production.
On Request